Michigan Medicine Opens First Clinic in the United States That Focuses on Prostate Cancer Risk

It’s well known that women with certain hereditary genetic mutations, particularly BRCA1 and BRCA2, have an increased risk of breast cancer. But in recent years, researchers have discovered a link between some of those same genetic mutations – along with a handful of others – and aggressive prostate cancer. Todd Morgan, M.D., is the Michigan Medicine urological surgeon behind a new Prostate Cancer Risk Clinic at the University of Michigan. It’s the first of its kind in the nation.

Read more.